216
Participants
Start Date
July 6, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
BAT8006 for Injection
Intravenous infusion, once every 3 weeks (Q3W), the recommended infusion time of the first cycle is ≥90 minutes, if no infusion reaction occurs, the subsequent cycle can be completed within 30\~120 minutes.
RECRUITING
Anhui Cancer Hospital, Hefei
NOT_YET_RECRUITING
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Sun Yat-Sen Memorlal Hospital, Sun Yat-Sen University, Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
RECRUITING
Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute, Nanning
RECRUITING
Hubei Cancer Hospital, Wuhan
RECRUITING
Tongji Hospital, Tongji Medical College of Hust, Wuhan
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
Zhongnan Hospital of Wuhan University, Wuhan
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
The First Hospital of Jilin University, Changchun
NOT_YET_RECRUITING
Liaoning Cancer Hospital&Institute, Shenyang
RECRUITING
Shandong Cancer Hospital, Jinan
NOT_YET_RECRUITING
Shanxi Provincial Cancer Hospital, Taiyuan
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Lead Sponsor
Bio-Thera Solutions
INDUSTRY